CHICAGO--(BUSINESS WIRE)--CytoCore (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, today announced financial results for the second quarter 2007.
CHICAGO--(BUSINESS WIRE)--CytoCore (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, today announced financial results for the second quarter 2007.